Latest Writings

I attend the Sartorius Upstream/Downstream Bioprocessing forum, a conference sponsored by the company that takes place at their conference center in Goettingen, Germany. The conference brings together some of the movers and shakers in the world of bioprocessing in an exciting review of the latest developments. I write up the proceedings of the conference every year in a report, published in Genetic Engineering and Biotechnology News.

See: Morrow, K. J. 2016. Upstream Tools Hasten Product Development: Beware of Obstructions in the Upstream Processing of Biologics.  Genetic Engineering and Biotechnology News. Sep 15, 36(16):32-35. http://www.genengnews.com/gen-articles/upstream-tools-hasten-product-development/5837/?kwrd=morrow. for my latest article.

I maintain a long standing interest in the threat of biological warfare, and I have followed developments in this field with interest over the years. For my latest writings in this area please check out: Morrow, K. J. 2016. The Dark Side of CRISPR FrontLine Security 11:(4).  http://security.frontline.online/article/2016/4/5714-The-Dark-Side-of-CRISPR.

In December of 2016 Wiley Publishers released Biosimilars of Monoclonal Antibodies: A Practical Guide to Manufacturing, Preclinical and Clinical Development, a collection of essays on antibody technology. My colleague, Dr. Cheng Liu and I edited the book, which we believe will be an important addition to the literature in this field. KJ Morrow, C Liu - 2016 - books.google.com.

Morrow, J. 2017. How A Biotech Startup Networked Through The Valley Of Death. Life Science Leader. July 2017.


 


*